A5102831756- Retinopathy of Prematurity Studies
- Retinal Diseases and Treatments
- Retinal and Macular Surgery
- Neonatal Respiratory Health Research
- Glaucoma and retinal disorders
- Neonatal and fetal brain pathology
- Vascular Malformations Diagnosis and Treatment
- Preterm Birth and Chorioamnionitis
- Neonatal Health and Biochemistry
- Intraocular Surgery and Lenses
- Ocular Diseases and Behçet’s Syndrome
- Ophthalmology and Visual Impairment Studies
- Cerebral Venous Sinus Thrombosis
- Neonatal and Maternal Infections
- Histiocytic Disorders and Treatments
- Renal cell carcinoma treatment
- Toxoplasma gondii Research Studies
- Ocular Surface and Contact Lens
- Hepatitis B Virus Studies
- Retinal Development and Disorders
- Yersinia bacterium, plague, ectoparasites research
- Retinoids in leukemia and cellular processes
- Ocular Infections and Treatments
- Tuberous Sclerosis Complex Research
- Ophthalmology and Eye Disorders
Tabriz University of Medical Sciences
2011-2025
Eye Center
2022
Retinopathy of prematurity (ROP) is a proliferative disorder the developing retina. Intravitreal bevacizumab injection (IVB) an emerging treatment for severe forms ROP, which does not restrict visual field in comparison to laser therapy. The present study aimed determine and evaluate risk factors ROP recurrence following IVB injection.
Background: Eyes are the most sensitive organs to sulfur mustard (SM). Late ocular complications have been reported even 15–20 years post-exposure. To date, no study has investigated composition of tear proteins in samples SM-intoxicated patients.Methods: Total protein content as well concentrations vascular endothelial growth factor (VEGF), calcitonin gene related peptide (CGRP) and substance P were measured unstimulated tears chemically-injured patients who suffer from late SM. These...
Purpose: To evaluate the efficacy and safety of intravitreal injection (IVI) bevacizumab (IVB) versus aflibercept (IVA) in premature infants with type 1 prethreshold retinopathy prematurity (ROP) posterior Zone II. Methods: The study was a multicenter, historical cohort newborns diagnosed ROP II, treated IVB or IVA. Demographic features, complications, treatment outcomes were then compared between two groups. Results: Seventy-six patients received (the IVA group), 210 group). groups not...
To investigate retinal layers' thickness and vascular density after successful scleral buckle surgery using the optical coherence tomography angiography (OCTA) method.In this prospective interventional case-control study, 24 patients with macular-off rhegmatogenous detachment (RRD) were included performing reattachment by buckling. Retinal assessed in OCTA method compared to normal fellow eyes as controls 10 months postoperation.Inner layers showed no significant difference, but there was a...
Objectives: Due to recent advances in caring for premature neonates, retinopathy has become an important cause of preventable blindness and ocular disabilities. Therefore, more attention is paying its diagnostic-therapeutic methods. Thus, the current trial assessed efficacy oral propranolol on treatment prematurity (ROP) neonates. Materials Methods: In trial, 58 neonates with ROP were included (0.5 mg/kg every 8 hours) was compared control group. Results: intervention group, stage almost...
Abstract Background Retinopathy of prematurity (ROP) is a proliferative disorder the developing retina. Intravitreal bevacizumab injection (IVB) an emerging treatment for ROP one treatments has many benefits. The present study aimed to determine and evaluate risk factors recurrence following IVB injection. Materials method In this retrospective study, 98 eyes 49 infants with who had received injections as primary type 1 are included. Results Fifty-four (55.1%) Aggressive posterior...
Our study aims to evaluate and compare the macular microvascular condition of intravitreal Bevacizumab (IVB)-treated retinopathy prematurity (ROP) cases preterm without ROP spontaneously regressed ROPs. It is a retrospective cohort 50 premature neonates visited from 2016 2017 for screening in Nikookari Eye Hospital recalled re-evaluation 2022. These patients were classified into three groups based on their medical documents: 1. Preterm (PT), 2. Spontaneously ROPs (SR), 3. IVB-treated (IVB)....
Objectives: This study aimed to investigate the effects of bevacizumab (an anti-VEGF antibody) on structure retina such as thickness nerve fiber layer and macula with optical coherence tomography (OCT) in retinopathy prematurity (ROP) patients. Materials Methods: cross-sectional was conducted 2021-2022 Tabriz, Iran preterm children aged 4-6 years. To this end, a total 300 eyes 150 were assigned three groups then examined by performing Fundus examination retina, eye refraction test, OCT...
Introduction : Because of increasing the population premature infants due to improving neonatal care we try find other independent criteria in addition birth weight and gestational age reduce number who need a retinopathy prematurity (ROP) screening examination. Methods This is retrospective cross-sectional study, included 150 preterm with ≤ 32 weeks or 1500 g receives oxygen therapy for more than 2 days, were examined from fourth week life ROP Tabriz Al-Zahra hospital’s intensive unit...
Introduction: Since retinopathy of prematurity (ROP) is a preventable cause blindness in children, evaluation declared criteria for their screening crucial. The aim this study to evaluate the incidence disease Nikukari Eye Hospital according gestational age and neonatal birth weight. Methods: In cross-sectional study, after determining frequency based on patients referred ROP clinic, neonates were divided into groups 500 1000 g, 1001 1500 1501 2000 above 28 weeks, 28-30 30-32 32-34 over 34...
Abstract Purpose the purpose of this study is to investigate effects bevacizumab on structure retina such as thickness nerve fiber layer and macula with OCT in ROP patients. Methods 300 eyes from 150 children underwent Fundus examination, refraction 3 groups consist 100 a history that were treated bevacizumab, improved spontaneously third group preterm without ROP. Results Foveal was 235.46 ± 11 µm receiving 267.70 12 spontaneous improvement ROP, no it 269.48 10 micrometers. So mean fovea...